Cost-effectiveness analysis of using innovative therapies for the management of moderate-to-severe ulcerative colitis in Spain-Reference-Cited by-同舟云学术

Cost-effectiveness analysis of using innovative therapies for the management of moderate-to-severe ulcerative colitis in Spain

Published:2021-02-20 Issue:1 Volume:22 Page:73-83
ISSN:1473-7167
Container-title:Expert Review of Pharmacoeconomics & Outcomes Research
language:en
Short-container-title:Expert Review of Pharmacoeconomics & Outcomes Research

Author:

Taxonera Carlos¹^ORCID,de Andrés-Nogales Fernando²^ORCID,García-López Santiago³,Sánchez-Guerrero Amelia⁴,Menchén Belén⁴,Peral Carmen⁵,Cábez Ana⁵,Gómez Susana⁵,López-Ibáñez de Aldecoa Alejandra⁵,Casado Miguel Ángel²,Menchén Luis⁶⁷

Affiliation:

1. Department of Gastroenterology. Hospital Clínico Universitario San Carlos, And Instituto De Investigación Del Hospital Clínico San Carlos [Idissc], Madrid, Spain

2. Health Economics, Pharmacoeconomics & Outcomes Research Iberia (PORIB), Madrid, Spain

3. Department of Gastroenterology. Hospital Universitario Miguel Servet, Zaragoza, Spain

4. Hospital Pharmacy Department Hospital Universitario Puerta De Hierro-Majadahonda, Madrid, Spain

5. Pfizer S.L.U, Alcobendas, Madrid, Spain

6. Department of Gastroenterology. Hospital General Universitario Gregorio Marañón, And Instituto De Investigación Sanitaria Gregorio Marañón, Madrid, Spain

7. Department of Medicine, Universidad Complutense De Madrid, Madrid, Spain

Funder

Pfizer S.L.U

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Health Policy,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/14737167.2021.1880324

Reference48 articles.

1. Third European Evidence-based Consensus on Diagnosis and Management of Ulcerative Colitis. Part 1: Definitions, Diagnosis, Extra-intestinal Manifestations, Pregnancy, Cancer Surveillance, Surgery, and Ileo-anal Pouch Disorders

2. Ulcerative colitis

3. Ulcerative Colitis

4. Epidemiology and hospital resources use in the treatment of ulcerative colitis at gastroenterology units in Spain (EPICURE study)

5. Systematic review: the costs of ulcerative colitis in Western countries

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cost-Effectiveness Analysis of Tofacitinib Compared with Biologics in Biologic-Naïve Patients with Moderate-to-Severe Ulcerative Colitis in Japan;PharmacoEconomics;2023-03-08

2. Cost-effectiveness analysis of the first‐line EGFR‐TKIs in patients with advanced EGFR-mutated non-small-cell lung cancer;Expert Review of Pharmacoeconomics & Outcomes Research;2021-10-11